Avita Medical Inc
Research Avita Medical Inc (AVH) on Bullrun: market cap AUD 166.96M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAVH
- ExchangeAU
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 166.96M
- Financial periodQ4 2025
- RevenueAUD 17.62M
- Net income-AUD 11.62M
- Free cash flow-AUD 5.46M
- Gross margin81.2%
Valuation Snapshot
latest market cap is AUD 166.96M.
About Avita Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2;
Frequently asked questions
What is Avita Medical Inc's market cap?
Avita Medical Inc's market capitalization is AUD 166.96M.
What does Avita Medical Inc do?
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.